Ananda Basu, MD
Basu A. Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients. Ann Intern Med. 2010;152:JC2–13. doi: 10.7326/0003-4819-152-4-201002160-02013
Download citation file:
Published: Ann Intern Med. 2010;152(4):JC2-13.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use